Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

被引：16

作者：

Vance, Jeffery M. ^{[1
]}

Farrer, Lindsay A. ^{[2
,3
,4
,5
,6
]}

Huang, Yadong ^{[7
]}

Cruchaga, Carlos ^{[8
]}

Hyman, Bradley T. ^{[9
]}

Pericak-Vance, Margaret A. ^{[1
]}

Goate, Alison M. ^{[10
,11
]}

Greicius, Michael D. ^{[12
]}

Griswold, Anthony J. ^{[13
]}

Haines, Jonathan L. ^{[14
]}

Julia, T. C. W. ^{[15
,16
,17
]}

Schellenberg, Gerard D. ^{[18
]}

Tsai, Li-Huei ^{[19
]}

Herz, Joachim ^{[20
,21
,22
]}

Holtzman, David M. ^{[23
]}

机构：

[1] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, John T McDonald Dept Human Genet, Miami, FL USA

[2] Boston Univ, Dept Med Biomed Genet, Chobanian & Avedisian Sch Med, Boston, MA USA

[3] Boston Univ, Dept Neurol, Chobanian & Avedisian Sch Med, Boston, MA USA

[4] Boston Univ, Dept Ophthalmol, Chobanian & Avedisian Sch Med, Boston, MA USA

[5] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[6] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA

[7] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Gladstone Ctr Translat Advancement, Dept Neurol, San Francisco, CA USA

[8] Washington Univ St Louis, Dept Psychiat, St Louis, MO USA

[9] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Alzheimer Res Unit,Inst Neurodegenerat Dis, Boston, MA USA

[10] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, Dept Genet, New York, NY USA

[11] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, Dept Genom Sci, New York, NY USA

[12] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA USA

[13] Univ Miami, Dr John T Macdonald Fdn, John P Hussman Inst Human Genom, Miller Sch Med,Dept Human Genet, Miami, FL USA

[14] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA

[15] Chobanian & Avedisian Sch Med, Dept Pharmacol, Boston, MA USA

[16] Chobanian & Avedisian Sch Med, Dept Physiol & Biophys, Boston, MA USA

[17] Boston Univ, Fac Comp & Data Sci, Bioinformat Program, Boston, MA USA

[18] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA

[19] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA USA

[20] UT Southwestern, Dept Mol Genet, Ctr Translat Neurodegenerat Res, Dallas, TX USA

[21] UT Southwestern, Dept Neurosci, Ctr Translat Neurodegenerat Res, Dallas, TX USA

[22] UT Southwestern, Dept Neurol, Ctr Translat Neurodegenerat Res, Dallas, TX USA

[23] Washington Univ St Louis, Dept Neurol, Hope Ctr Neurol Disorders, Knight Alzheimers Dis Res Ctr, St Louis, MO USA

来源：

ANNALS OF NEUROLOGY | 2024年 / 95卷 / 04期

关键词：

TAU-MEDIATED NEURODEGENERATION; APOLIPOPROTEIN-E GENOTYPE; A-BETA ACCUMULATION; MOUSE MODEL; AMYLOID DEPOSITION; PLAQUE-FORMATION; TYPE-4; ALLELE; RISK; AGE; ASSOCIATION;

D O I：

10.1002/ana.26864

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Alzheimer's disease (AD) is the most common neurodegenerative disorder and one of the leading causes of disability worldwide. The apolipoprotein E4 gene (APOE4) is the strongest genetic risk factor for AD. In 2023, the APOE4 National Institute on Aging/Alzheimer's Disease Sequencing Project working group came together to gather data and discuss the question of whether to reduce or increase APOE4 as a therapeutic intervention for AD. It was the unanimous consensus that cumulative data from multiple studies in humans and animal models support that lowering APOE4 should be a target for therapeutic approaches for APOE4 carriers. ANN NEUROL 2024

引用

页码：625 / 634

页数：10

共 74 条

[1] Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report [J].

Arboleda-Velasquez, Joseph F. ;

Lopera, Francisco ;

O'Hare, Michael ;

Delgado-Tirado, Santiago ;

Marino, Claudia ;

Chmielewska, Natalia ;

Saez-Torres, Kahira L. ;

Amarnani, Dhanesh ;

Schultz, Aaron P. ;

Sperling, Reisa A. ;

Leyton-Cifuentes, David ;

Chen, Kewei ;

Baena, Ana ;

Aguillon, David ;

Rios-Romenets, Silvia ;

Giraldo, Margarita ;

Guzman-Velez, Edmarie ;

Norton, Daniel J. ;

Pardilla-Delgado, Enmanuelle ;

Artola, Arabiye ;

Sanchez, Justin S. ;

Acosta-Uribe, Juliana ;

Lalli, Matthew ;

Kosik, Kenneth S. ;

Huentelman, Matthew J. ;

Zetterberg, Henrik ;

Blennow, Kaj ;

Reiman, Rebecca A. ;

Luo, Ji ;

Chen, Yinghua ;

Thiyyagura, Pradeep ;

Su, Yi ;

Jun, Gyungah R. ;

Naymik, Marcus ;

Gai, Xiaowu ;

Bootwalla, Moiz ;

Ji, Jianling ;

Shen, Lishuang ;

Miller, John B. ;

Kim, Leo A. ;

Tariot, Pierre N. ;

Johnson, Keith A. ;

Reiman, Eric M. ;

Quiroz, Yakeel T. .

NATURE MEDICINE, 2019, 25 (11) :1680-+

[2] A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward [J].

Belloy, Michael E. ;

Napolioni, Valerio ;

Greicius, Michael D. .

NEURON, 2019, 101 (05) :820-838

[3] Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice [J].

Bien-Ly, Nga ;

Gillespie, Anna K. ;

Walker, David ;

Yoon, Seo Yeon ;

Huang, Yadong .

JOURNAL OF NEUROSCIENCE, 2012, 32 (14) :4803-4811

[4] APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes [J].

Blanchard, Joel W. ;

Akay, Leyla Anne ;

Davila-Velderrain, Jose ;

von Maydell, Djuna ;

Mathys, Hansruedi ;

Davidson, Shawn M. ;

Effenberger, Audrey ;

Chen, Chih-Yu ;

Maner-Smith, Kristal ;

Hajjar, Ihab ;

Ortlund, Eric A. ;

Bula, Michael ;

Agbas, Emre ;

Ng, Ayesha ;

Jiang, Xueqiao ;

Kahn, Martin ;

Blanco-Duque, Cristina ;

Lavoie, Nicolas ;

Liu, Liwang ;

Reyes, Ricardo ;

Lin, Yuan-Ta ;

Ko, Tak ;

R'Bibo, Lea ;

Ralvenius, William T. ;

Bennett, David A. ;

Cam, Hugh P. ;

Kellis, Manolis ;

Tsai, Li-Huei .

NATURE, 2022, 611 (7937) :769-+

[5] Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes [J].

Blanchard, Joel W. ;

Bula, Michael ;

Davila-Velderrain, Jose ;

Akay, Leyla Anne ;

Zhu, Lena ;

Frank, Alexander ;

Victor, Matheus B. ;

Bonner, Julia Maeve ;

Mathys, Hansruedi ;

Lin, Yuan-Ta ;

Ko, Tak ;

Bennett, David A. ;

Cam, Hugh P. ;

Kellis, Manolis ;

Tsai, Li-Huei .

NATURE MEDICINE, 2020, 26 (06) :952-+

[6] Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics [J].

Blue, Elizabeth E. ;

Horimoto, Andrea R. V. R. ;

Mukherjee, Shubhabrata ;

Wijsman, Ellen M. ;

Thornton, Timothy A. .

ALZHEIMERS & DEMENTIA, 2019, 15 (12) :1524-1532

[7] STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES [J].

BRAAK, H ;

BRAAK, E .

NEUROBIOLOGY OF AGING, 1995, 16 (03) :271-278

[8] Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance [J].

Castellano, Joseph M. ;

Kim, Jungsu ;

Stewart, Floy R. ;

Jiang, Hong ;

DeMattos, Ronald B. ;

Patterson, Bruce W. ;

Fagan, Anne M. ;

Morris, John C. ;

Mawuenyega, Kwasi G. ;

Cruchaga, Carlos ;

Goate, Alison M. ;

Bales, Kelly R. ;

Paul, Steven M. ;

Bateman, Randall J. ;

Holtzman, David M. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (89)

[9] Ancestry-related differences in chromatin accessibility and gene expression of APOE ε4 are associated with Alzheimer's disease risk [J].

Celis, Katrina ;

Moreno, Maria D. M. Muniz ;

Rajabli, Farid ;

Whitehead, Patrice ;

Hamilton-Nelson, Kara ;

Dykxhoorn, Derek M. ;

Nuytemans, Karen ;

Wang, Liyong ;

Flanagan, Margaret ;

Weintraub, Sandra ;

Geula, Changiz ;

Gearing, Marla ;

Dalgard, Clifton L. ;

Jin, Fulai ;

Bennett, David A. ;

Schuck, Theresa ;

Pericak-Vance, Margaret A. ;

Griswold, Anthony J. ;

Young, Juan I. ;

Vance, Jeffery M. .

ALZHEIMERS & DEMENTIA, 2023, 19 (09) :3902-3915

[10]

Chemparathy A., 2023, NEURON

← 1 2 3 4 5 6 7 8 →